Review



113cd 201113a fluidigm  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    fluidigm 113cd 201113a fluidigm
    113cd 201113a Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/113cd+201113a+fluidigm/Maxpar+MCP9+Antibody+Labeling+Kit/pmc12368159__41698_2025_1091_MOESM1_ESM-3-352-354
    Average 93 stars, based on 4 article reviews
    113cd 201113a fluidigm - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Clinical Proteomics:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Control:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Biomarker Discovery:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Purification:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Recombinase Polymerase Amplification:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Labeling:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.

    Antibody Labeling:

    Article Title: APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer
    Article Snippet: No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 13042 12805 46.66 22.82 2 CD8 T cells 2808 5196 10.05 9.26 3 Treg cells 2536 3980 9.07 7.09 4 NK 1793 2188 6.41 3.90 5 Naive/memory B cells 4348 9673 15.55 17.24 6 Plasma cells 697 3657 2.49 6.52 7 Neutrophils 1084 8560 3.88 15.25 8 APOE high myeloid cells 478 4298 1.71 7.66 9 FCN1 high myeloid cells 521 2195 1.86 3.91 10 HLA-DQA1 high myeloid cells 557 1638 1.99 2.92 11 pDCs 89 493 0.32 0.88 12 undetermined lymphocyte 1 1434 0.00 2.56 No Cluster Freq_Control Freq_Metastatic Percent_Control Percent_Metastatic 1 CD4 T cells 7391 939 49.57 14.62 2 CD8 T cells 1297 605 8.70 9.42 3 Treg cells 784 304 5.26 4.73 4 NK 160 343 1.07 5.34 5 Naive/memory B cells 4618 2042 30.97 31.79 6 Plasma cells 485 145 3.25 2.26 7 APOE high myeloid cells 14 1607 0.09 25.02 8 FCN1 high myeloid cells 14 265 0.09 4.13 9 HLA-DQA1 high myeloid cells 146 152 0.98 2.37 10 pDC 2 21 0.01 0.33 Table S2 Cell number and proportions of major immune cell types identified in scRNA-seq analysis from control and metastatic LNs of validation cohort Reagents tag clone PN Source Anti-Human CD45 89Y HI30 3089003B Fluidigm Purified anti-human CD223 (LAG-3) Antibody* 113Cd 11C3C65 369302 BioLegend Anti-Human CD19 142Nd HIB19 3142001B Fluidigm Anti-human CD11b 144Nd ICRF44 3144001B Fluidigm Anti-human CD64 146Nd 10.1 3146006B Fluidigm Anti-human CD103 151Eu Ber-ACT8 3151011B Fluidigm Anti-human CD66b 152Sm 80H3 3152011B Fluidigm Anti-human Tim3 154Sm F38-2E2 3154010B Fluidigm Anti-human CD123 155Gd 6H6 3143014B Fluidigm Anti-human CD11c 159Tb Bu15 3159001B Fluidigm Anti-human CD14 160Gd M5E2 3160001B Fluidigm Anti-human CTLA4 161Dy 14D3 3161004B Fluidigm Anti-human CD56 163Dy NCAM16.2 3163007B Fluidigm Anti-human CD16 165Ho B73.1 3165007B Fluidigm Purified anti-human CD4 (Maxpar® Ready) Antibody** 166Er RPA-T4 300541 BioLegend Anti-human CD206 168Er 15-2 3168008B Fluidigm Anti-human CD8 168Er SK1 3168002B Fluidigm Anti-human CD3 170Er UCHT1 3170001B Fluidigm Anti-human HLA-DR 174Yb L243 3174001B Fluidigm Anti-human PD1 175Lu EH12.2H7 3175008B Fluidigm Anti-human TIGIT 209Bi MBSA43 3209013B Fluidigm Iridium 201192A Fluidigm * Metal labeled by Maxpar MCP9 Antibody Labeling Kit, 113Cd 201113A Fluidigm **Metal labeled by Maxpar® X8 Antibody Labeling Kit, 166Er—4 Rxn 201166A Fluidigm Table S3 Antibody list for CyTOF analysis A B Fig S1.



    Similar Products

    113cd 201113a fluidigm  (fluidigm)
    93
    fluidigm 113cd 201113a fluidigm
    113cd 201113a Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/113cd+201113a+fluidigm/Maxpar+MCP9+Antibody+Labeling+Kit/pmc12368159__41698_2025_1091_MOESM1_ESM-3-352-354
    Average 93 stars, based on 1 article reviews
    113cd 201113a fluidigm - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    113cd fluidigm  (fluidigm)
    93
    fluidigm 113cd fluidigm
    113cd Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/113cd+201113a+fluidigm/Maxpar+MCP9+Antibody+Labeling+Kit/pm36099881-556-315-316
    Average 93 stars, based on 1 article reviews
    113cd fluidigm - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results